Related Experiment Video
Updated: Aug 15, 2026

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
Light (phototherapy)--induced riboflavin deficiency in the neonate
Insights
Phototherapy for neonatal jaundice can cause riboflavin deficiency. Infants receiving over 49 hours of blue light treatment showed signs of deficiency, indicating a potential clinical concern.
Area of Science:
- Biochemistry
- Neonatal Medicine
- Nutritional Science
Background:
- Phototherapy is a common treatment for neonatal hyperbilirubinemia.
- Blue light used in phototherapy can degrade riboflavin (Vitamin B2).
- Riboflavin status is crucial for infant metabolism and development.
Purpose of the Study:
- To investigate the incidence of riboflavin deficiency in neonates undergoing phototherapy.
- To determine if phototherapy duration correlates with riboflavin deficiency.
- To assess the clinical relevance of riboflavin depletion in treated neonates.
Main Methods:
- Studied 21 neonates with hyperbilirubinemia, 16 receiving phototherapy.
- Used erythrocyte glutathione reductase saturation to assess riboflavin status.
- Compared infants receiving phototherapy with a control group not requiring treatment.
Main Results:
- 16 out of 21 infants (76%) exposed to phototherapy developed riboflavin deficiency.
- All infants treated for 49 hours or more showed signs of deficiency.
- Control infants without phototherapy did not develop riboflavin deficiency.
Conclusions:
- Phototherapy for neonatal hyperbilirubinemia can lead to significant riboflavin deficiency.
- The duration of phototherapy is a key factor in developing this deficiency.
- This deficiency may have important clinical and metabolic implications for newborns.
Abstract:
Phototherapy with blue light decomposes riboflavin, which has a maximum absorption at 450 nm. A study was designed to determine whether riboflavin deficiency developed in neonates who received phototherapy for moderate hyperbilirubinemia. Twenty-one infants with normal erythrocyte glucose-6-phosphate dehydrogenase activity were investigated. Five infants with moderate hyperbilirubinemia who did not require phototherapy served as the controls. Riboflavin deficiency was determined from the degree of saturation of erythrocyte glutathione reductase, a method shown to reflect riboflavin nutritional status in the neonate. Sixteen of 21 infants who were exposed to phototherapy developed riboflavin deficiency; all who had phototherapy for 49 hours or more developed the deficiency. That the concentration of serum bilirubin or the duration of hyperbilirubinemia was not a factor is supported by the fact that none of the controls became deficient. This observation may have important metabolic and clinical consequences for the neonate.
Related Concept Videos
Photoreceptors and Plant Responses to Light
Photoreceptors and Visual Pathways
Drug Dosing: Infants and Children
Acne Infection

